Simon Tiberi - GlaxoSmithKline | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

Honorary Consultant in Infectious Diseases at the Department of Infection, Barts Health NHS Trust. Research in general Infectious Diseases with a focus on TB, Mycobacteria, respiratory infections and antimicrobials.

研究兴趣

论文共 227 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Corrigendum to “mycobacterium Avium Infection in a Patient with Metal-on-metal Hip Prosthesis” [clin. Infect. Pract., 20(suppl. 1) (2023) Abstract 80]

Cecilia Mifsud,Simon Tiberi, Jonathan Ward, Albert Mifsud

Clinical Infection in Practice（2024）

引用0浏览0引用

A First-in-class Leucyl-Trna Synthetase Inhibitor, Ganfeborole, for Rifampicin-Susceptible Tuberculosis: a Phase 2a Open-Label, Randomized Trial

Andreas H. Diacon,Clifton E. Barry III,Alex Carlton,Ray Y. Chen,Matt Davies,Veronique de Jager,Kim Fletcher, Gavin C. K. W. Koh,Irina Kontsevaya,Jan Heyckendorf, Christoph Lange,Maja Reimann, Sophie L. Penman,Rhona Scott,Gareth Maher-Edwards,Simon Tiberi,Georgios Vlasakakis,Caryn M. Upton,David Barros Aguirre

NATURE MEDICINEno. 3 (2024)

引用0浏览0WOSNATURE引用

Evaluation of Effectiveness and Safety of Delamanid-Containing Regimens Using Individual Patient Datasets

D R Silva,R Centis, L D'Ambrosio,D Visca,S Tiberi,O Akkerman, M Lipman, G B Migliori

The international journal of tuberculosis and lung disease the official journal of the International Union against Tuberculosis and Lung Diseaseno. 9 (2024): 470-472

引用0浏览0WOS引用

Expert Views on Screening for Tuberculosis Infection in Patients Commencing Treatment with a Biologic Agent